Greenleaf Trust Purchases 611 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Greenleaf Trust increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,522 shares of the company’s stock after purchasing an additional 611 shares during the period. Greenleaf Trust’s holdings in GE HealthCare Technologies were worth $504,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Chicago Capital LLC raised its position in shares of GE HealthCare Technologies by 2.8% during the 3rd quarter. Chicago Capital LLC now owns 6,081 shares of the company’s stock valued at $414,000 after purchasing an additional 163 shares during the period. Chilton Capital Management LLC increased its holdings in GE HealthCare Technologies by 15.4% in the 4th quarter. Chilton Capital Management LLC now owns 1,227 shares of the company’s stock valued at $95,000 after acquiring an additional 164 shares during the last quarter. Procyon Advisors LLC increased its holdings in GE HealthCare Technologies by 5.2% in the 4th quarter. Procyon Advisors LLC now owns 3,555 shares of the company’s stock valued at $275,000 after acquiring an additional 175 shares during the last quarter. Meeder Advisory Services Inc. increased its holdings in GE HealthCare Technologies by 5.4% in the 4th quarter. Meeder Advisory Services Inc. now owns 3,634 shares of the company’s stock valued at $281,000 after acquiring an additional 185 shares during the last quarter. Finally, Forum Financial Management LP increased its holdings in GE HealthCare Technologies by 3.9% in the 3rd quarter. Forum Financial Management LP now owns 4,989 shares of the company’s stock valued at $339,000 after acquiring an additional 186 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Price Performance

GEHC stock opened at $84.31 on Tuesday. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18. The company has a 50-day moving average price of $88.76 and a 200 day moving average price of $78.08. The stock has a market cap of $38.47 billion, a PE ratio of 27.92, a P/E/G ratio of 2.94 and a beta of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The firm had revenue of $5.20 billion during the quarter, compared to analysts’ expectations of $5.09 billion. During the same period in the previous year, the company earned $1.31 EPS. The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a dividend of $0.03 per share. The ex-dividend date is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is presently 3.97%.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the stock. Citigroup lifted their price target on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Mizuho lifted their price target on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, April 11th. UBS Group upgraded shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lifted their price target for the company from $66.00 to $88.00 in a report on Monday, February 12th. Evercore ISI lifted their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. Finally, Argus lifted their price objective on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, April 1st. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $95.09.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.